Alpha 2.0
Login Register
» Articles » PMID: 18671799

SUR Receptor Activity Vs. Incidence of Hypoglycaemia and Cardiovascular Mortality with Sulphonylurea Therapy for Diabetics

Overview
Journal Diabetes Obes Metab
Specialty Endocrinology
Date 2008 Aug 2
PMID 18671799
Citations 6
Authors
J Tayek
Affiliations
Soon will be listed here.
Citing Articles

[Diabetic kidney disease (update 2023) : Position paper of the Austrian Diabetes Association and the Austrian Society for Nephrology].

Sourij H, Edlinger R, Prischl F, Kaser S, Horn S, Antlanger M Wien Klin Wochenschr. 2023; 135(Suppl 1):182-194.

PMID: 37101040 PMC: 10133372. DOI: 10.1007/s00508-022-02147-3.

[Diabetic kidney disease (Update 2019) : Position paper of the Austrian Diabetes Association and the Austrian Society for Nephrology].

Sourij H, Edlinger R, Prischl F, Auinger M, Kaser S, Horn S Wien Klin Wochenschr. 2019; 131(Suppl 1):151-163.

PMID: 30980144 DOI: 10.1007/s00508-018-1425-x.

[Diabetic kidney disease - Update 2016].

Sourij H, Edlinger R, Prischl F, Auinger M, Kautzky-Willer A, Saemann M Wien Klin Wochenschr. 2016; 128 Suppl 2:S85-96.

PMID: 27052231 DOI: 10.1007/s00508-016-0992-y.

A double-blind, randomized trial, including frequent patient-physician contacts and Ramadan-focused advice, assessing vildagliptin and gliclazide in patients with type 2 diabetes fasting during Ramadan: the STEADFAST study.

Hassanein M, Abdallah K, Schweizer A Vasc Health Risk Manag. 2014; 10:319-26.

PMID: 24920915 PMC: 4045264. DOI: 10.2147/VHRM.S64038.

Experience with DPP-4 inhibitors in the management of patients with type 2 diabetes fasting during Ramadan.

Schweizer A, Halimi S, Dejager S Vasc Health Risk Manag. 2014; 10:15-24.

PMID: 24391442 PMC: 3878957. DOI: 10.2147/VHRM.S54585.